Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

SDS Eye Irritation Test: Methods, Standards, and Applications

The SDS eye irritation test evaluates the ocular irritation potential of sodium dodecyl sulfate and surfactant-based formulations using validated in vitro and in vivo methods aligned with OECD guidelines. This technical article explains the testing principles, sample types, regulatory standards, and practical applications of eye irritation assessment in cosmetics, chemicals, and consumer product safety evaluation.

SDS Eye Irritation Test

Technical Overview

Sodium dodecyl sulfate (SDS), also known as sodium lauryl sulfate (SLS), is an anionic surfactant widely incorporated into detergents, shampoos, toothpastes, and industrial cleaning formulations. Because surfactants frequently come into accidental contact with the eyes during product use, evaluating their ocular irritation potential is a core requirement of chemical and cosmetic safety assessment. The SDS eye irritation test therefore refers to the systematic evaluation of eye irritation and corrosion hazards associated with SDS and SDS-containing products.

Historically, ocular irritation was assessed using the in vivo rabbit Draize test (OECD Test Guideline 405). However, growing ethical concerns and regulatory restrictions, particularly the EU animal testing bans for cosmetics, have driven the adoption of in vitro alternatives. These include the Bovine Corneal Opacity and Permeability test (OECD TG 437), the Isolated Chicken Eye test (OECD TG 438), the Short Time Exposure test (OECD TG 491), and reconstructed human cornea-like epithelium methods such as EpiOcular and SkinEthic (OECD TG 492). SDS itself plays a dual role in this field: it is both a frequently tested substance and a well-characterized positive control used to demonstrate assay proficiency and sensitivity.

Test results are interpreted according to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), which distinguishes between Category 1 (serious eye damage, irreversible effects), Category 2 (reversible eye irritation), and no classification. Accurate categorization directly determines hazard labeling, handling precautions, and market access for finished products.

Testing Samples

Surfactants and Raw Materials

Pure surfactant ingredients, including SDS, sodium laureth sulfate, betaines, and nonionic surfactants, can be submitted for hazard characterization prior to formulation. Concentration-dependent irritation profiling is often performed to establish safe use levels.

Cosmetic and Personal Care Products

Rinse-off products such as shampoos, facial cleansers, body washes, and hand soaps are the most common sample category, given their high surfactant content and realistic exposure scenarios near the ocular surface. Leave-on products, eye-area cosmetics, and baby care formulations are also routinely evaluated.

Household and Industrial Chemicals

Laundry detergents, dishwashing liquids, multi-purpose cleaners, degreasers, and institutional cleaning concentrates require eye hazard classification under GHS and regional chemical regulations such as REACH.

Pharmaceutical and Biocide Formulations

Excipients, preservative systems, disinfectants, and topical drug formulations may undergo ocular irritation assessment as part of safety dossiers or occupational exposure evaluations.

Testing Items

Eye irritation testing programs typically address the following endpoints and classification decisions:

  • GHS Category 1 identification: serious eye damage indicated by corneal opacity, iritis, or persistent effects not resolving within 21 days.
  • GHS Category 2 identification: reversible eye irritation involving corneal effects, conjunctival redness, or chemosis that fully resolves within 21 days.
  • No label requirement confirmation for substances demonstrating no irritant potential.
  • Corneal opacity scores and fluorescein permeability values (BCOP in vitro irritancy score).
  • Cell viability measurements following chemical exposure in reconstructed tissue and STE assays.
  • Concentration-response analysis, including IC50 determination for cytotoxicity-based assays.
  • Comparative benchmarking against SDS reference concentrations to position test article potency.

Testing Methods

Method selection depends on the physicochemical properties of the test article, the regulatory purpose, and whether a top-down (identifying serious damage) or bottom-up (ruling out irritation) strategy is applied.

Bovine Corneal Opacity and Permeability Test (OECD TG 437)

Isolated bovine corneas are exposed to the test substance, and changes in light transmission (opacity) and sodium fluorescein penetration (permeability) are quantified. The combined in vitro irritancy score supports identification of Category 1 ocular corrosives and severe irritants. SDS is commonly employed as a positive control, with expected score ranges predefined by the guideline.

Isolated Chicken Eye Test (OECD TG 438)

Enucleated chicken eyes are treated with the test article and evaluated for corneal opacity, fluorescein retention, epithelial swelling, and morphological changes. The method is suited to identifying serious eye damage and works well for both liquids and solids.

Short Time Exposure Test (OECD TG 491)

Rabbit corneal epithelial cells in culture are exposed to the test chemical for short durations, and viability is measured via colorimetric assay. This method is specifically applicable to water-soluble surfactants and surfactant-based formulations, making it particularly relevant for SDS-type samples.

Reconstructed Human Cornea-like Epithelium Test (OECD TG 492)

Three-dimensional human corneal tissue models such as EpiOcular and SkinEthic are topically exposed to the test article, followed by MTT viability assessment. Reduced viability below the classification threshold indicates the test article is an eye irritant. This bottom-up approach is widely used for cosmetic ingredients and mild formulations.

In Vivo Rabbit Eye Test (OECD TG 405)

The traditional Draize test is retained only as a last resort when in vitro data are inconclusive and the information is essential for hazard classification. It involves instillation of the test substance into one eye of a rabbit with sequential scoring of cornea, iris, and conjunctiva reactions under strict animal welfare supervision.

Applications

Eye irritation test data generated with SDS and related surfactants support a broad range of regulatory and commercial objectives:

  • Cosmetic safety dossiers demonstrating compliance with EU Regulation (EC) No 1223/2009 and equivalent regulations in China, ASEAN markets, and elsewhere.
  • GHS labeling and safety data sheet preparation for industrial and household chemical products.
  • REACH registration support for substance volumes requiring ocular hazard characterization.
  • Formulation optimization, allowing developers to compare candidate surfactant systems and document claims such as "no more tears" or ophthalmologist-tested positioning.
  • Benchmark testing of positive reference materials and laboratory proficiency demonstration during method validation.
  • Occupational risk assessment for manufacturing and professional cleaning environments.

FAQ

Why is SDS used as a reference material in eye irritation testing?

SDS has an extensively documented irritation profile validated across multiple in vitro and in vivo methods. Its reproducible, moderate-to-severe response makes it an ideal positive control for verifying that test systems and laboratory procedures perform within acceptance criteria.

Can in vitro methods fully replace animal testing for eye irritation?

Validated in vitro methods approved under OECD guidelines can identify serious eye damage and detect the absence of irritation for most substance classes. However, distinguishing moderate reversible irritation at borderlines may still require weight-of-evidence assessment combining multiple alternative methods before considering any in vivo follow-up.

How much sample is required for testing?

Typical submission requirements range from 20 to 100 grams or milliliters depending on the selected method, the number of replicates, and whether concentration-response testing is requested.

What is the typical turnaround time?

Individual in vitro assays are generally completed within one to three weeks after sample receipt, while multi-method testing strategies and full regulatory packages may require four to eight weeks.

Which reporting standards apply?

Reports are issued in accordance with OECD Principles of Good Laboratory Practice where applicable, including detailed protocols, raw data, acceptance criteria verification, and GHS classification conclusions suitable for submission to regulatory authorities.

Why Choose ZKGX?

  • State-of-the-art analytical equipment
  • Highly qualified scientific team
  • Fast turnaround time
  • Competitive pricing